SCHEMBL26329922

SCHEMBL26329922

c1ccc(-n2c3ccc(-n4c5ccccc5c5ccc6c(c7ccccc7n6-c6ccccc6)c54)cc3c3ccncc32)cc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.43
ATM Q13315 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CDK4 P11802 3/20 0.39
CDK6 Q00534 3/20 0.39
DYRK1A Q13627 2/20 0.34
TOP2A P11388 1/20 0.33
CYP1A2 P05177 1/20 0.33
METAP2 P50579 1/20 0.33
GSK3B P49841 1/20 0.32
KCNH2 Q12809 1/20 0.32
ALDH1A1 P00352 1/20 0.32
REN P00797 1/20 0.32
RAC2 P15153 1/20 0.32
RAC3 P60763 1/20 0.32
CDC42 P60953 1/20 0.32
RAC1 P63000 1/20 0.32
JAK2 O60674 1/20 0.32
JAK3 P52333 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26329923 0.96 KDM4E (0.39) KDM4EATML3MBTL1CDK4CDK6
SCHEMBL15436385 0.94 KDM4E (0.49) KDM4EATML3MBTL1CDK4CDK6
SCHEMBL26329936 0.93 KDM4E (0.43) KDM4EATML3MBTL1CDK4CDK6
SCHEMBL26329911 0.93 KDM4E (0.43) KDM4EATML3MBTL1CDK4CDK6
SCHEMBL26329916 0.93 KDM4E (0.43) KDM4EATML3MBTL1CDK4CDK6
SCHEMBL26329772 0.93 KDM4E (0.47) KDM4EATML3MBTL1CDK4CDK6
SCHEMBL21453857 0.91 KDM4E (0.41) KDM4EATML3MBTL1CDK4CDK6
SCHEMBL21454370 0.91 KDM4E (0.41) KDM4EATML3MBTL1CDK4CDK6
SCHEMBL15436384 0.90 KDM4E (0.40) KDM4EATML3MBTL1CDK4CDK6
SCHEMBL13556835 0.89 KDM4E (0.44) KDM4EATML3MBTL1CDK4CDK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11723269-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-08-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11723269-B2 Organic electroluminescent materials and devices PUF60, CD99, DDT KDM4E 3163/4885ATM 3362/4885L3MBTL1 1292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.